Ravid Straussman
Impact in
- Oncology top 0.5%
- Pancreatic and Hepatic Oncology Research
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
- Biotechnology top 0.1%
- Cancer Research and Treatments
Papers in
-
- Cancer Research and Treatments 12
-
- Gut microbiota and health 14
- Epigenetics and DNA Methylation 4
- Cancer-related gene regulation 3
- Co-authors
- Jennifer Ann Wargo (3 shared papers)laurence ZITVOGEL (1 shared paper)Rob Knight (1 shared paper)Jeff Hasty (1 shared paper)Gregory D. Sepich‐Poore (1 shared paper)Howard Cedar (4 shared papers)Zohar Yakhini (3 shared papers)Itamar Simon (2 shared papers)
- Journals
- Science (4 papers)Nature Cancer (3 papers)Cell (3 papers)Cancer Cell (3 papers)Nature Communications (3 papers)
- Partner nations
- IsraelUnited StatesUnited Kingdom
In The Last Decade
Ravid Straussman
45 papers receiving 13.0k citations
Ravid Straussman's Hit Papers
Peers
Comparison fields: 5 of 151
- Oncology 4.4k
- Biotechnology 1.5k
- Molecular Biology 7.8k
- Cancer Research 1.3k
- Biological Psychiatry 203
Countries citing papers authored by Ravid Straussman
This map shows the geographic impact of Ravid Straussman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ravid Straussman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ravid Straussman more than expected).
Fields of papers citing papers by Ravid Straussman
This network shows the impact of papers produced by Ravid Straussman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ravid Straussman. The network helps show where Ravid Straussman may publish in the future.
Co-authors
The 25 scholars most cited alongside Ravid Straussman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The human tumor microbiome is composed of tumor type–specific intracellular bacteria Hit paper breakdown → | 2020 | 1840 |
| 2 | Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion Hit paper breakdown → | 2012 | 1512 |
| 3 | Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine Hit paper breakdown → | 2017 | 1437 |
| 4 | Tumor Microbiome Diversity and Composition Influence Pancreatic Cancer Outcomes Hit paper breakdown → | 2019 | 1230 |
| 5 | The microbiome and human cancer Hit paper breakdown → | 2021 | 985 |
| 6 | Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer Hit paper breakdown → | 2006 | 947 |
| 7 | Widespread Genetic Heterogeneity in Multiple Myeloma: Implications for Targeted Therapy Hit paper breakdown → | 2014 | 819 |
| 8 | Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response Hit paper breakdown → | 2021 | 716 |
| 9 | Breast cancer colonization by Fusobacterium nucleatum accelerates tumor growth and metastatic progression Hit paper breakdown → | 2020 | 540 |
| 10 | Microbiome and cancer Hit paper breakdown → | 2021 | 444 |
| 11 | 2014 | 402 | |
| 12 | Pan-cancer analyses reveal cancer-type-specific fungal ecologies and bacteriome interactions Hit paper breakdown → | 2022 | 391 |
| 13 | Identification of bacteria-derived HLA-bound peptides in melanoma Hit paper breakdown → | 2021 | 346 |
| 14 | 2009 | 315 | |
| 15 | 2021 | 210 | |
| 16 | 2020 | 155 | |
| 17 | 2019 | 98 | |
| 18 | 2021 | 82 | |
| 19 | 2017 | 70 | |
| 20 | 2020 | 70 |
About Ravid Straussman
Ravid Straussman is a scholar working on Biotechnology, Molecular Biology, Oncology, Cell Biology and Cancer Research, having authored 45 papers that have together received 13.2k indexed citations. Recurring topics across this work include Gut microbiota and health (14 papers), Cancer Research and Treatments (12 papers), Pancreatic and Hepatic Oncology Research (6 papers), Cancer Cells and Metastasis (5 papers), Cancer Genomics and Diagnostics (4 papers), Cellular Mechanics and Interactions (4 papers), Epigenetics and DNA Methylation (4 papers) and Cancer-related gene regulation (3 papers). The work is most often cited by research in Oncology (4.4k citations), Biotechnology (1.5k citations), Molecular Biology (7.8k citations), Cancer Research (1.3k citations) and Biological Psychiatry (203 citations). Ravid Straussman has collaborated with scholars based in Israel, United States and United Kingdom. Frequent co-authors include Jennifer Ann Wargo, laurence ZITVOGEL, Rob Knight, Jeff Hasty, Gregory D. Sepich‐Poore, Howard Cedar, Zohar Yakhini, Itamar Simon, Michal Barzily-Rokni and Zachary Aaron Cooper. Their work appears in journals such as Science, Nature Cancer, Cell, Cancer Cell and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.